BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/22/2015 2:02:00 PM | Browse: 1126 | Download: 1807
 |
Received |
|
2015-03-31 08:06 |
 |
Peer-Review Started |
|
2015-03-31 10:28 |
 |
To Make the First Decision |
|
2015-04-23 13:14 |
 |
Return for Revision |
|
2015-04-30 16:50 |
 |
Revised |
|
2015-05-02 03:11 |
 |
Second Decision |
|
2015-05-20 07:51 |
 |
Accepted by Journal Editor-in-Chief |
|
2015-05-22 04:13 |
 |
Accepted by Executive Editor-in-Chief |
|
2015-05-27 19:55 |
 |
Articles in Press |
|
2015-05-27 19:55 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2015-06-27 15:53 |
 |
Publish the Manuscript Online |
|
2015-07-22 13:58 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Topic Highlights |
Article Title |
CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer
|
Manuscript Source |
Invited Manuscript |
All Author List |
Michael Bordonaro and Darina L Lazarova |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Institutes of Health (Bethesda, MD) National Cancer Institute |
1R15CA149589-01 |
|
Corresponding Author |
Michael Bordonaro, PhD, Associate Professor of Molecular Biology, Department of Basic Sciences, The Commonwealth Medical College, 525 Pine Street, Scranton, PA 18509, United States. mbordonaro@tcmedc.org |
Key Words |
CREB-binding protein; p300; Wnt; Colorectal cancer; Butyrate; Stem cells |
Core Tip |
Deregulated Wnt/?-catenin signaling is responsible for initiating most human colorectal cancer (CRC), and hyperactivation of this pathway by histone deacetylase inhibitors such as butyrate, derived from dietary fiber, promotes CRC cell death. The transcriptional cofactors CREB-binding protein (CBP) or p300 affect Wnt signaling and the hyperactivation of this pathway by butyrate. CBP and p300 likely affect colonic tumorigenesis, stem cell fate, and butyrate resistance in CRC. Therefore, pharmacological or genetic methodologies that target CBP- and p300-mediated Wnt activity are possible preventive or therapeutic approaches against CRC. |
Publish Date |
2015-07-22 13:58 |
Citation |
Bordonaro M, Lazarova DL. CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer. World J Gastroenterol 2015; 21(27): 8238-8248 |
URL |
http://www.wjgnet.com/1007-9327/full/v21/i27/8238.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v21.i27.8238 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345